ISRG is positioning da Vinci 5 as a TAM expander, targeting cardiac surgery long term while advancing near-term regulatory ...
Hosted on MSN
Intuitive Surgical updates 2025 da Vinci procedure growth guidance to 15.5%-17% as da Vinci 5 launches expand
David J. Rosa, CEO, opened with recognition of Gary Guthart’s transition to Executive Chair, stating his excitement to lead Intuitive forward and emphasizing the company’s strong financial metrics for ...
At the end of the third quarter of 2025, Intuitive Surgical had placed 10,763 of its da Vinci surgical robot systems into ...
3d
How Investors May Respond To Intuitive Surgical (ISRG) Surging da Vinci Usage and New FDA Approvals
In recent days, Intuitive Surgical reported strong demand for its da Vinci robotic systems, with procedure volumes rising ...
Intuitive Surgical ISRG stock has delivered a strong recent run, rising 32.4% over the past three months and currently ...
Intuitive Receives FDA Clearance for da Vinci SP Surgical System for Transanal Colorectal Procedures
Intuitive's da Vinci SP surgical system receives FDA clearance for transanal local resection, enhancing minimally invasive colorectal surgery options. Intuitive, a leader in robotic-assisted surgery, ...
Shares of Intuitive Surgical soared after the maker of robotic surgery systems posted higher sales and profit for the third quarter and said it expects higher growth for its da Vinci surgery system ...
Intuitive Surgical, Inc. (NASDAQ:ISRG) reported third-quarter financial results after markets closed on Thursday. Here’s a rundown of everything you need to know. Q3 Earnings Top Estimates: Intuitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback